In a conversation with Abby Kim, Pharm.D., of Prime Therapeutics, she shared that oncology pharmacists bridge critical gaps in precision medicine, enhancing patient care by streamlining biomarker testing and ensuring timely access to effective treatments.
In this interview, Abbey Berenson, M.D., MMS, Ph.D., director for the Center of Interdisciplinary Research in Women's Health at the University of Texas Medical Branch, discusses the potential of self-swabbing for HPV screening to improve early detection of cervical cancer, particularly for underserved populations, while emphasizing the necessity of follow-up with healthcare providers.
Stereotactic ablative radiotherapy, also referred to as stereotactic body radiation therapy, has emerged as a standard noninvasive treatment alternative, offering high local control rates with relatively limited toxicity in carefully selected patients.
Medicare’s recently released drug pricing models GLOBE and GUARD use international price benchmarks to generate government rebates but experts say they are unlikely to reduce costs for patients.
Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal Cancers Symposium earlier this month in San Francisco.
A study using global health records reports that color-blind individuals face higher bladder cancer mortality, potentially due to delayed detection of blood in urine, while no similar survival difference is seen in colorectal cancer.
Duravyu demonstrated vision improvement in phase 2 trials in patients with diabetic macular edema. Phase 3 trials are enrolling patients now.
New research revealed that many genetic variants linked to inherited retinal diseases rarely cause vision loss, challenging previous assumptions about their impact.
In 2024, U.S. health care spending rose to $5.3 trillion, driven by increased per capita use and demand for medical services as utilization rebounded following the COVID-19 pandemic.
A long-term UK Biobank analysis shows that while early or surgical menopause initially appears linked to higher diabetes rates, this association disappears after accounting for lifestyle and cardiovascular risk factors rather than menopause timing itself.
Carbohydrate counting involves blood glucose checks before and after meals, calculating carbohydrate consumption, and then adjusting insulin accordingly.
Several lines of evidence suggest that testing the traditional drug for diabetes might benefit people with idiopathic pulmonary fibrosis.
Combining NB-UVB light therapy with ruxolitinib cream enhances skin repigmentation in vitiligo patients, showing promising results without safety concerns.
United States health care spending rose to $5.3 trillion in 2024, accounting for 18% of the economy, as strong post-pandemic demand and high insurance coverage continued to drive costs upward.
Beginning this month, PBMs in California must prioritize health plan interests over their own, and CVS Caremark’s CalPERS contract includes $250 million in performance guarantees.
CHOP partners with Soar Autism Center to enhance early autism care access, reducing wait times and providing integrated therapy services for families.
A recent study found that TikTok videos about breast cancer screening created by physicians are more accurate and reliable than those made by nonphysicians or private clinics, highlighting both the platform’s growing role in health education and persistent quality gaps.
Discover the effectiveness of sonic sleep aids, revealing which audio tools truly enhance sleep quality and which may not deliver on their promises.
Existing medications for narcolepsy aim for symptom control. But therapies in development are targeting the specific mechanism of the disease and the brain’s natural sleep-wake cycle.
A recent study reveals ustekinumab outperforms adalimumab and secukinumab in drug survival for psoriasis, guiding treatment decisions for patients.
Five experimental drugs show promise in significantly lowering lipoprotein(a). The furthest along is pelacarsen, with phase 3 results expected in the first half of this year, and regulatory filings in the second half of this year.
A nationwide randomized study showed that risk-based breast cancer screening safely detects cancer while reducing unnecessary screening for low-risk women and is favored by most patients over annual mammograms.
In a wide-ranging interview, Mitchell discussed the Purchaser Business Group Health’s health data demonstration project, employer fiduciary responsibility, consequences of the end of enhanced Affordable Care Act subsidies and direct contracting.
Shekhar Khera, senior vice president, product management at RxBenefits, discusses the role of artificial intelligence in healthcare and how his company is using it to improve efficiency, outcomes and the member experience.
The PBM association also appointed Brendan Buck chief communications officer. Both Marin and Buck begin Jan. 20, 2026.
Independence Blue Cross announces three out of five 2026 Clinical Care Innovation Grants to enhance healthcare access and outcomes through innovative projects by leading health systems.
Despite widespread exposure to breast cancer misinformation that heightened fear in many patients, a survey found it did not lead to increased treatment nonadherence.
A phase 3 trial offers new evidence that an immunotherapy drug may outperform chemotherapy for acral melanoma, a rare subtype long underrepresented in clinical research.
Post-hoc analysis shows potential of biomarkers for identifying pancreatic patients who respond to treatment.
AI transforms how Americans navigate the complex healthcare system, offering timely support and enhancing decision-making for patients and providers alike.
